Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
3.510
+0.240 (7.34%)
Aug 15, 2025, 4:00 PM - Market closed
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $108.77 million as of August 15, 2025. Its market cap has decreased by -25.04% in one year.
Market Cap
108.77M
Enterprise Value
60.55M
1-Year Change
-25.04%
Ranking
Category
Stock Price
$3.51
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $108.77M, a decrease of -69.46%. That is a compound annual growth rate of -58.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 108.80M | 26.66% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 630.91B |
| Johnson & Johnson | 425.94B |
| AbbVie | 365.11B |
| UnitedHealth Group | 280.11B |
| AstraZeneca | 243.29B |
| Novartis AG | 236.22B |
| Abbott Laboratories | 229.13B |
| Novo Nordisk | 225.09B |